See more : Nyquest Technology Co., Ltd. (6494.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of LLA.L,0P0001T9GN,0 (LLA.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of LLA.L,0P0001T9GN,0, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- First Citrus Bancorporation, Inc. (FCIT) Income Statement Analysis – Financial Results
- Prime Urban Development India Limited (PRIMEURB.BO) Income Statement Analysis – Financial Results
- Mitek Systems, Inc. (MITK) Income Statement Analysis – Financial Results
- Monte Carlo Fashions Limited (MONTECARLO.BO) Income Statement Analysis – Financial Results
- Fountaine Pajot Société anonyme (ALFPC.PA) Income Statement Analysis – Financial Results
LLA.L,0P0001T9GN,0 (LLA.L)
About LLA.L,0P0001T9GN,0
LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. The company engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. LungLife AI, Inc. was incorporated in 2009 and is based in Thousand Oaks, California.
Source: https://incomestatements.info
Category: Stock Reports